Reduction of Adverse Drug Events and Readmissions — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Reduction of Adverse Drug Events and Readmissions — Stella

Recruiting

Back to Pharmacogenomic Testing for Medication Management trials

Trial locations(1 site)

United States

MD@Home, York, Pennsylvania

Key details

Sponsor

ClinLogic LLC

Enrollment target

~280,000 participants

Started

March 2019

Primary completion

March 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

25 Years and older

Last updated February 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov